Skip to main content
. Author manuscript; available in PMC: 2024 Jul 6.
Published in final edited form as: Dev Dyn. 2021 Jan 26;250(5):684–700. doi: 10.1002/dvdy.293

TABLE 2.

Primers and gBlocks

SYBRGreen assay

Gene Forward sequence (5′ > 3′) Reverse sequence (5′ > 3′)
OTX2 TTCGGGTATGGACTTGCTGC GATGTCTGGGTACCGGGTCT
GATA4 TCTACATGAAGCTCCACGGG TGAAGGAGCTGCTGGTGTC
SOX17 AAGGGCGAGTCCCGTATC TTGTAGTTGGGGTGGTCCTG
SOX9 GAGGAAGTCGGTGAAGAACG ATCGAAGGTCTCGATGTTGG
PAX6 TCTTTGCTTGGGAAATCCG CTGCCCGTTCAACATCCTTAG
CTTNBP2 CCCCGTGGGACTTTATGAGG GCCTTCTTGAGGACCTGACA
PGK1 TAACAAGCTGACGCTGGAC GCAGCCTTAATCCTCTGGTT
TaqMan assay

Gene Sequence (5′ > 3′)
CFTR AGCTGTCAAGCCGTGTTCTAGATA
ATGAGGAGTGCCACTTGCAAA
/56-FAM/CACACGAAA/ZEN/TGTGCCAATGCAAGTCCTT/3IABkFQ/
PGK1 TAACAAGCTGACGCTGGAC
GCAGCCTTAATCCTCTGGTT
/56-JOEN/CGACTCTCA/ZEN/TAACGACCCGCTTCC/3IABkFQ/
ChIP-qPCR

Amplicon site Forward sequence (5′ > 3′) Reverse sequence (5′ > 3′)
18s CGGCTACCACATCCAAGGAA GCTGGAATTACCGCGGCT
NARG2/ICE2 promoter GGAAAGGGGACGCAAAGAGA TCCTACCCCTGCTTTGCTTG
RNF111 promoter CACGTACAGTTTTGGTGGCG AGTAATGCGTCGAGAGCCAG
ATP6V0A4 i9/10 AAGGTGCCAAAAATGGAGTG AGGAGAGTTCAAGGCCAGGT
GRM8 promoter CCAATCAAGCTCCAATGCCC TGTGAGAGAAATAGCGGGCG
APIP promoter TTATCTTGTGGGCTTCCCCG AATTAGCTCCGCGGCTTACA
EOMES Promoter TTTCGCCGGAATTTAGGGGG ATGACTAATGCGCCAAGGGT
EHF promoter TCCCGGTTGGTGGCTTATTG GGCACCACGGGTGTTATCAA
CFTR −0.5 kb promoter GTTCTCCCGCCGGTGG CAGTCGCGGCCTCTCTTTAG
CFTR DHS10a,b TGCTTTATTGAATGGCATTACCTCTA AGATGCTTGTGGTAAGGGAGGAG
CFTR i20 AGGATGCCAGACAGGGAGAT ACCTTTTGCCCCTCAGCTTT
CFTR +15.6 kb ATCCATTTTCTTCAAGTCTCTCTCCAT GGAATGAGGATTGTTTATGATTTGG
CFTR +19.6 kb CTGCAAGTATTTCTTGGATGCTGT GTAACCCATTTGGCTTGAGGG
CFTR +21.5 kb GGCTAGTTCCTTGACCTGAACAA TGGAAGTTCCTCCATTTTGAATG
CFTR +22.6 kb GCCAGGGAATGAGTCTTGTG GCCTCCTGTTCTTCCCAAAT
CFTR +48.9 kb GGCATCAGCCAGTCAAGGTTT AGCAGAGGGCAAGTGGTACTT
+22.6 kb deletion

Name Sequence (5′ > 3′)
+22.6 kb 5′ gBlock TGTACAAAAAAGCAGGCTTTAAAGGAACCAATTCAGTCGACTGGATCCGGTACCAAGGTCGGGCA
GGAAGAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATACGATACAAGGCTGTTAGAGAGATAAT
TAGAATTAATTTGACTGTAAACACAAAGATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTT
GGGTAGTTTGCAGTTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTATT
TCGATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGTTCAAGACTACTTGCACGG
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGA
GTCGGTGCTTTTTTTCTAGACCCAGCTTTCTTGTACAAAGTTGGCATTA
+22.6 kb 3′ gBlock TTGTACAAAAAAGCAGGCTTTAAAGGAACCAATTCAGTCGACTGGATCCGGTACCAAGGTCGGGCAGGA
AGAGGGCCTATTTCCCATGATTCCTTCATATTTGCATATACGATACAAGGCTGTTAGAGAGATAATTAG
AATTAATTTGACTGTAAACACAAAGATATTAGTACAAAATACGTGACGTAGAAAGTAATAATTTCTTGG
GTAGTTTGCAGTTTTAAAATTATGTTTTAAAATGGACTATCATATGCTTACCGTAACTTGAAAGTATTTC
GATTTCTTGGCTTTATATATCTTGTGGAAAGGACGAAACACCGTACTCACACCGTCGCCAGA
GTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGGCTAGTCCGTTATCAACTTGAAAAAGTGGCACCGA
GTCGGTGCTTTTTTTCTAGACCCAGCTTTCTTGTACAAAGTTGGCATTA
+22.6 kb EF TGGCACTCTCCTTCTGTGTG
+22.6 kb ER CAGGGCATCTTCTGGCTTAC
+22.6 kb IF GCCAGGGAATGAGTCTTGTG
+22.6 kb IR ACTCATTCCCTGGCTTCCTT
4C-seq primers

Name Reading primer (5′ > 3′) Nonreading primer (5′ > 3′)
CFTR +22.6 kb viewpoint TACACGACGCTCTTCCGATCTCAAA
CATCCTGGTAAACCATG
ACTGGAGTTCAGACGTGTGCTCTTCCGATCTGC
ACTTATCACTAGCTAATGT

Abbreviations: CFTR, cystic fibrosis transmembrane conductance regulator; ChIP-qPCR, Chromatin immunoprecipitation followed by qPCR; CTTNBP2, cortactin binding protein 2; OTX2, orthodenticle homeobox 2.